CareDx Inc. reports second-quarter results today after the market close, delivering the company’s first financial update since Medicare finalized a coverage policy affirming reimbursement for its transplant surveillance tests across kidney, heart, and lung patients—a decision that sent shares surgin...
stock
Be The Investor Research
Read Original Source (Investing)
CareDx earnings on deck: Guidance in focus after Medicare LCD
CareDx Inc. reports second-quarter results today after the market close, delivering the company’s first financial update since Medicare finalized a coverage policy affirming reimbursement for its transplant surveillance tests across kidney, heart, and lung pat
